Paydirt
Insider filing · NGNE

Christine Mikail Cvijic bought $492K of Neurogene (NGNE)

Executed Nov 22 2024, disclosed Nov 25 2024, 3 days later.

Value, as filed
$492K
24,000 sh × $20.48
Executed
Nov 22 2024
the trade date, as filed
Disclosed
Nov 25 2024
3 days after the trade
Return, 21 sessionsiFrom the disclosed entry session; derived
+7.5%
+45.3% from execution

Over the 21 trading sessions from the disclosed entry session (Nov 25 2024), the stock returned +7.5% (delay-adjusted); from the execution session (Nov 22 2024), +45.3%. Derived: entry at the session's open, exit at the close 20 sessions later.

The filer
CC Christine Mikail Cvijic President and CFO profile →

Christine Mikail Cvijic (President and CFO) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Neurogene Inc. (NGNE). The largest single filing was $300K of NGNE (9,600 sh across 2 lots, as filed), executed May 6.

The name
NGNE Neurogene Inc. NGNE · Healthcare · 7 filings in 24 months ticker →

Healthcare · Neurogene Inc., a clinical stage biotechnology company, develops genetic medicines for rare neurological diseases

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→
Other filings by Christine Mikail Cvijic in NGNE
NGNESALE Neurogene Inc. $152K
4,200 sh × $36.13
Exec Jul 7
Filed Jul 7 · 9:08 PM ET NGNESALE Neurogene Inc. $300K
9,600 sh across 2 lots
Exec May 6
Filed May 8 · 5:30 PM ET NGNESALE Neurogene Inc. $121K
4,800 sh × $25.11
Exec Feb 27
Filed Mar 3 · 5:30 PM ET